Shandong Weigao Group Medical Polymer Company Limited (“Weigao Group”) has released an overseas regulatory announcement in compliance with Rule 13.10B of the Hong Kong Stock Exchange Listing Rules.

The company disclosed that Shandong Weigao Orthopaedic Device Company Limited has published an announcement on the Shanghai Stock Exchange’s website (http://www.sse.com.cn/home/search/?webswd=688161). The Hong Kong filing serves to mirror that disclosure for international investors and ensure alignment with cross-border reporting requirements.

The statement reiterates that Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited assume no responsibility for the contents of the announcement.

Corporate governance details were also provided: the Weigao Group Board currently comprises four Executive Directors (Long Jing, Cong Rinan, Lu Junqiang, Wang Daoming), two Non-executive Directors (Chen Lin, Tang Zhengpeng) and four Independent Non-executive Directors (Li Guohui, Meng Hong, Li Qiang, Sun Heng).

The announcement was authorised by Chairman Long Jing and dated 25 August 2026 in Weihai, Shandong, PRC.